Physician
Gastroenterology
Dr. Andrew D. Rhim, MD
Andrew Rhim works in the field of Gastroenterology. He went to Perelman School of Medicine at the University of Pennsylvania. He received awards:"CMS Meaningful Use Stage 1 Certification". Andrew D. Rhim is a published doctor. He published 25 publications, including: 'A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results.' Andrew D. Rhim, MD accepts all Medicare patients.
Publications
- Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
- A new scalpel for the treatment of pancreatic Cancer: Targeting stromal-derived STAT3 signaling.
- Polarization of the vacuolar adenosine triphosphatase delineates a transition to high-grade pancreatic intraepithelial Neoplasm lesions.
- Molecular biology of pancreatic ductal adenocarcinoma.
- Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic Cancer cells from blood cells with dielec...
- Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
- Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.
- Diagnosis of pernicious Anemia and the risk of pancreatic cancer.
- Detection of Circulating Pancreas Epithelial Cells in Patients with Pancreatic Cystic Lesions.
- Interleukin-6 is required for pancreatic Cancer progression by promoting MAPK signaling activation and oxidative stress resistance.
- IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in Colorectal cancer cell xenografts.
- Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic Cancer.
- A combined, rational approach towards inhibition of the MEK-ERK and mTOR pathways in pancreatic ductal adenocarcinoma: promise or deja vu?
- Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.
- A young woman with gallstone pancreatitis and abnormal liver tests: when is endoscopic retrograde cholangiopancreatography needed?
- The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's Disease.
- Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.
- Altered terminal glycosylation and the pathophysiology of CF lung Disease.
- Severity of liver Disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
- Terminal glycosylation of cystic fibrosis airway epithelial cells.
- Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
- Epithelial to mesenchymal transition and the generation of stem-like cells in pancreatic Cancer.
- Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells.
- A randomized phase II dose-response exercise trial among Colon Cancer Survivors: Purpose, Study Design, methods, and recruitment results.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Group Employees PPO
- Capital Blue Cross
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- HealthPartners
- Community Blue PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Philadelphia Veterans Affairs Medical Center -
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1134281470 | |
| NPPES Provider LastName | RHIM | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 481095362 | |
| NPPES Provider State | MI | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 23.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134281470 |
| Last Name Of The Provider | RHIM |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Eugenius S. Ang, MD |
|
|
Dr. Paula G. Davey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Del Valle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William D. Chey, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Beth R. Manoogian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle K. Turgeon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William M. Cooney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick K. Askari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas D. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip S. Schoenfeld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dejan Micic, MD |
|
|
Dr. Richard S. Kwon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|